Abbott Laboratories ABT
NYSE ABT
$107.25 -2.04 (-1.87%)
At close: Nov 12, 2026 · 4:02 PM EST

Abbott Laboratories (ABT) Net Income towards Common Stockholders (2009 - 2026)

Updated

Abbott Laboratories (ABT) recorded Net Income towards Common Stockholders of $920 million in Q3 2026, down 44.0% from $1.64 billion a year earlier and down 0.9% from the prior quarter.

Analysis

Abbott Laboratories (ABT) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

On a TTM basis, Abbott Laboratories' Net Income towards Common Stockholders came in at $4.7 billion as of Sep 30, 2026, down 66.4% year-over-year; for FY2025, it came in at $6.52 billion, down 51.3% from FY2024.

  • Annual Net Income towards Common Stockholders has a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
  • Across earlier years, Net Income towards Common Stockholders came in at $13.4 billion in FY2024 (+134.2%), $5.72 billion in FY2023 (-17.5%), $6.93 billion in FY2022 (-1.5%) and $7.04 billion in FY2021 (+57.4%).
  • The Q3 2026 figure is the lowest quarterly Net Income towards Common Stockholders since Q2 2020.
  • On a year-over-year basis, Net Income towards Common Stockholders has declined for five consecutive quarters, with growth averaging 41.5% over the last eight quarters.
  • Peak year-over-year performance for Net Income towards Common Stockholders in the last five years was growth of 479.0% in Q4 2024, against a decline of 80.8% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $928 million (Q2 2026), $1.08 billion (Q1 2026) and $1.78 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Thermo Fisher Scientific 259.20 Bn 235.84 Bn 5.13 Bn 1.72 Bn
2 Abbott Laboratories 185.80 Bn 160.26 Bn 7.39 Bn 920.00 Mn
3 Danaher 161.92 Bn 141.57 Bn 3.84 Bn 1.24 Bn
4 Intuitive Surgical 155.43 Bn 135.72 Bn 2.08 Bn 522.80 Mn
5 Medtronic 131.93 Bn 97.45 Bn 6.34 Bn 1.47 Bn
6 Stryker 119.74 Bn 105.93 Bn 4.25 Bn 753.00 Mn
7 Boston Scientific 64.30 Bn 59.73 Bn 3.43 Bn 582.00 Mn
8 Edwards Lifesciences 61.65 Bn 44.86 Bn 1.35 Bn 301.40 Mn
9 Agilent Technologies 48.79 Bn 41.68 Bn 1.04 Bn 362.00 Mn
10 GE HealthCare Technologies 37.34 Bn 25.57 Bn 2.22 Bn 615.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 920.00 Mn
Jun 30, 2026 928.00 Mn
Mar 31, 2026 1.08 Bn
Dec 31, 2025 1.78 Bn
Sep 30, 2025 1.64 Bn
Jun 30, 2025 1.78 Bn
Mar 31, 2025 1.33 Bn
Dec 31, 2024 9.23 Bn
Sep 30, 2024 1.65 Bn
Jun 30, 2024 1.30 Bn
Mar 31, 2024 1.23 Bn
Dec 31, 2023 1.59 Bn
Sep 30, 2023 1.44 Bn
Jun 30, 2023 1.38 Bn
Mar 31, 2023 1.32 Bn
Dec 31, 2022 1.03 Bn
Sep 30, 2022 1.44 Bn
Jun 30, 2022 2.02 Bn
Mar 31, 2022 2.44 Bn
Dec 31, 2021 1.98 Bn
API Access

Abbott Laboratories Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ABT&period=max&api_key=YOUR_API_KEY